Patent Foramen Ovale, Systemic Embolization, and Closure

Current Problems in Cardiology

Volumn 34, Issue 10, 2009, Pages 483-530

  Holmes Jr , David R ^a   Cohen, Howard A ^a   Ruiz, Carlos ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; EMBOLISM; HEART RIGHT LEFT SHUNT; HUMAN; MEDICAL DOCUMENTATION; MIGRAINE; PATENT FORAMEN OVALE; STROKE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; EMBOLISM, PARADOXICAL; FEMALE; FORAMEN OVALE, PATENT; HUMANS; INFANT; MALE; MIDDLE AGED; MIGRAINE DISORDERS; STROKE; YOUNG ADULT;

EID: 69449101949     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2009.06.001     Document Type: Article

References (83)

1. Zahn F.W. Thrombose de plusieurs branches de la veine cave inferieure avec embolies consecutives das les arteres pulmonair, splenique, renale et iliaque droite. Rev Med Suisse Rom 1 (1881) 227-237
2. Falk V., Walther T., Krankenberg H., et al. Trapped thrombus in a patent foramen ovale. J Thorac Cardiovasc Surg 45 (1997) 90-92
3. Fabricius A.M., Kruger M., Hanke M., et al. Caught in the act: Impending paradoxical embolism. Asian Cardiovasc Thorac Ann 10 (2002) 342-343
4. Maroto L.C., Molina L., Carrascal Y., et al. Intracardiac thrombus trapped in a patent foramen ovale. Eur J Cardio Thorac Surg 12 (1997) 807-810
5. Hanley P.C., Tajik A.J., Hynes J.K., et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol 6 (1985) 1370-1382
6. Gupta V., Yesilbursa D., Huang W.Y., et al. Patent foramen ovale in a large population of ischemic stroke patients: diagnosis, age, distribution, gender and race. Echocardiography 25 (2008) 217-227
7. Belvis R., Leta R.G., Marti-Fabregas J., et al. Almost perfect concordance between simultaneous transcranial Doppler and transesophageal echocardiography in the quantification of right to left shunts. J Neuroimaging 16 (2006) 133-138
8. Spencer M.P., Moehring M.A., Jesurum J., et al. Power m-mode transcranial Doppler for diagnosis of patent foramen ovale and assessing transcatheter closure. J Neuroimaging 14 (2004) 342-349
9. Del Sette M., Dinia L., Rizzi D., et al. Diagnosis of right to left shunt with transcranial Doppler and vertebrobasilar recording. Stroke 38 (2007) 2254-2256
10. Liboni W., Molinari F., Allais G.B., et al. Patent foramen ovale detected by near-infrared spectroscopy in patients suffering from migraine with aura. Neurol Sci 29 (2008) 5182-5185
11. Mohrs O.K., Petersen S.E., Erkapic D., et al. Dynamic contrast enhanced MRI before and after transcatheter occlusion of patent foramen ovale. AJR Am J Roentgenol 188 (2006) 844-849
12. Nusser T., Hoher M., Merkle N., et al. Cardiac magnetic resonance imaging and transesophageal echocardiography in patients with transcatheter closure of patent foramen ovale. J Am Coll Cardiol 48 (2006) 322-329
13. Ditullio M.R., Sacco R.L., Sciacca R.R., et al. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 49 (2007) 797-802
14. Meissner I., Khandheria B.K., Heit J.A., et al. Patent foramen ovale: innocent or guilty?. Evidence from a prospective population based study. J Am Coll Cardiol 47 (2006) 440-445
15. Petty G.W., Khandheria B.K., Meissner I., et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular events. Mayo Clin Proc 81 (2006) 602-608
16. Hagen P.T., Scholz D.G., and Edwards W.P. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 59 (1984) 17-20
17. Overell J.R., Bone I., and Lees K.R. Interatrial septal abnormalities and stroke-a meta-analysis of case-control studies. Neurology 55 (2000) 1172-1179
18. Heart Disease and Stroke Statistics 2003 update. Dallas, TX: American Heart Association.
19. Horton S.C., and Bunch T.J. Patent foramen ovale and stroke. Mayo Clin Proc 79 (2004) 15-20
20. Meissner I., Whisnant J.P., Khandheria B.K., et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study stroke prevention: assessment of risk in a community. Mayo Clin Proc 74 (1999) 862-869
21. Agmon Y., Khandheria B.K., Meissner I., et al. Comparison of frequency of patent foramen ovale by transesophageal echocardiography in patients with cerebral ischemic events versus in subjects in the general population. Am J Cardiol 88 (2001) 330-332
22. Lechat P., Mas J.L., Lascault G., et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318 (1988) 1148-1152
23. Homma S., Di Tullio M.R., Sacco R.L., et al. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 25 (1994) 582-586
24. Foster P., Boriek A.M., Butler B.D., et al. Patent foramen ovale and paradoxical systemic embolism: a bibliographic review. Aviat Space Environ Med 74 suppl S (2003) B1-B64
25. Di Tullio M., Sacco R.L., Gopal A., et al. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 117 (1992) 461-465
26. Windecker S., and Meier B. Patent foramen ovale and atrial septal aneurysm: when and how should they be treated?. ACC Curr J Rev 11 (2002) 97-101
27. Mas J.L., Arquizan C., Lamy C., et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm or both. N Engl J Med 345 (2001) 1740-1746
28. Mas J.L., Zuber M., and French Study Group. On patent foramen ovale and atrial septal aneurysm. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. Am Heart J 130 (1995) 1083-1088
29. Agmon Y., Khandheria B.K., Meissner I., et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 99 (1999) 1942-1944
30. Handke M., Harloff A., Olschewski M., et al. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 357 (2007) 2262-2268
31. Wilmshurst P.T., Nightingale S., Walsh K.P., et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 356 (2000) 1648-1651
32. Del Sette M., Angeli S., Leandri M., et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 8 (1998) 327-330
33. Wilmhurst P.T., Nightingale S., Walsh K.P., et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 356 (2000) 1648-1651
34. Morandi E., Anzola G.P., Angeli S., et al. Transcatheter closure of patent foramen ovale: a new migraine treatment?. J Int Cardiovasc 16 (2003) 39-42
35. Sztajzel R., Genoud D., Roth S., et al. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 13 (2002) 102-106
36. Dubiel M., Bruch L., Schmehl I., et al. Migraine headache relief after percutaneous transcatheter closure of interartrial communications. J Interven Cardiol 21 (2008) 32-37
37. Silberstein S. Oral presentation. TCT (2008)
38. Silberstein S. Recent developments in migraine. Lancet 372 (2008) 1369-1371
39. Cantais E.P., Louge P., Suppini A., et al. Right-to-left shunt and risk of decompression illness with cochleovestibular and cerebral symptoms in divers: Case control study in 101 consecutive dive accidents. Crit Care Med 31 (2003) 84-88
40. Walsh K.P., Wilmshurst P.T., and Morrison W.L. Transcatheter closure of patent foramen ovale using the Amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers. Heart 81 (1999) 257-261
41. Homma S., Sacco R.L., Di Tullio M.R., et al. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation 105 (2002) 2625-2631
42. Mohr J.P., Thompson J.L.P., Lazar R.M., et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 345 (2001) 1444-1451
43. Bogousslavsky J., Garazi S., Jeanrenaud X., et al. Lausanne Stroke with Paradoxical Embolism Study Group. Stroke recurrence in patients with patent foramen ovale: the Lausanne study. Neurology 46 (1996) 1301-1305
44. Onorato E., Melzi G., Casilli F., et al. Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients. J Int Cardiovasc 16 (2003) 43-50
45. Comess K.A., De Rook F.A., Beach K.W., et al. Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. J Am Coll Cardiol 23 (1994) 1598-1603
46. Khairy P., O'Donnell C.P., Landzbert M.J., et al. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical embolism: a systematic review. Ann Intern Med 9 (2003) 753-760
47. Windecker S., Wahl A., Chatterjee T., et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 101 (2000) 893-898
48. Wahl A., Meier B., Maxel B., et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 57 (2001) 1330-1332
49. Dearani J.A., Ugurlu B.S., Danielson G.K., et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 100 suppl II (1999) II171-II175
50. Homma S., Di Tullio M.R., Sacco R.L., et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 28 (1997) 2376-2381
51. Martin F., Sanchez P.L., Doherty E., et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 106 9 (2002) 1121-1126
52. Caes F.L., Van Belleghem Y.V., Missault L.H., et al. Surgical treatment of impending paradoxical embolism through patent foramen ovale. Ann Thorac Surg 59 (1995) 1559-1561
53. Hung J., Landzberg M.J., Jenkins K.J., et al. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 35 (2000) 1311-1316
54. Braun M.U., Fassbender D., Schoen S.P., et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 39 (2002) 2019-2025
55. Windecker S., Wahl A., Chatterjee T., et al. Percutaneous closure of PFO in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 101 (2000) 893-898
56. Brandt R.R., Neumann T., Neuzner J., et al. Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents. J Am Soc Echocardiogr 15 10 Pt. 1 (2002) 1094-1098
57. Braun M.U., Fassbender U.D., Schoen S.P., et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 39 (2002) 2019-2025
58. Bruch L., Parsi A., Grad M.O., et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: Single-center experience. Circulation 105 (2002) 2845-2848
59. Deeik R.K., Thomas R.M., Sakiyalak P., et al. Minimal access closure of patent foramen ovale: is it also recommended for patients with paradoxical emboli?. Ann Thorac Surg 74 (2002) S1326-S1329
60. Homma S., Di Tullio M.R., Sacco R.L., et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 28 (1997) 2376-2381
61. Devuyst G., Bogousslavsky J., Ruchat P., et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology 47 (1996) 1162-1166
62. Wahl A., Windecker S., Eberli F.R., et al. Percutaneous closure of patent foramen ovale in symptomatic patients. J Int Cardiovasc 14 (2001) 203-209
63. Windecker S., Wahl A., Chatterjee T., et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 101 (2000) 893-898
64. Meier B., and Lock J.E. Contemporary management of patent foramen ovale. Circulation 107 (2003) 5-9
65. Beitzke A., Schuchlenz H., Gamillscheg A., et al. Catheter closure of the persistent foramen ovale: mid-term results in 162 patients. J Int Cardiovasc 14 (2001) 223-229
66. Hijazi Z., Wang Z., Cao Q., et al. Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance: Feasibility and comparison with transesophageal echocardiography. Cath Cardiovasc Int 52 (2001) 194-199
67. Bartel T., Konorza T., Arjumand J., et al. Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications. Circulation 107 (2003) 795-797
68. Earing M.G., Cabalka A.K., Seward J.B., et al. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale. Mayo Clin Proc 79 (2004) 24-34
69. Ruiz C.E., Alboliras E.T., and Pophal S.G. The puncture technique: a new method for transcatheter closure of patent foramen ovale. Cathet Cardiovasc Intervent 53 (2001) 369-372
70. Spies C., Reissmann U., Timmermanns I., et al. Comparison of contemporary devices used for transcatheter patent foramen ovale closure. J Invasive Cardiol 20 (2008) 442-447
71. Sievert H., Horvath K., Zadan E., et al. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Int Cardiovasc 14 (2001) 261-266
72. Khositseth A., Cabalka A.K., Sweeney J.P., et al. Transcatheter device closure of atrial septal defect/patent foramen ovale in patients with presumed paradoxical embolism. Cathet Cardiovasc Interven 59 D-28 (2003) 150
73. Jesurum J.T., Fuller C.J., Kim C.J., et al. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right to left shunt. Am J Cardiol 102 (2008) 916-920
74. Nkomo V.T., Theuma P., Maniu C.V., et al. Patent foramen ovale transcatheter closure device thrombosis. Mayo Clin Proc 76 (2001) 1057-1061
75. Spies C., Khandelival A., Timmermanns I., et al. Recurrent events following patent foramen ovale closure in patients alive 55 years of age with presumed paradoxical embolism. Cathet Cardiovasc Interven 72 (2008) 966-970
76. Wahl A., Kunz M., Moschovitis A., et al. Long-term results after fluoroscopic guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart 94 (2000) 336-341
77. Slavin L., Tobis J.M., and Rangarian K. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol 99 (2007) 1316-1320
78. Braun M., Gliech V., Boscheri A., et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Eur Heart J 25 (2004) 424-430
79. Lange S.A., Schoen S.P., Braun M.U., et al. Perforation of aortic root as secondary complication after implantation of patent foramen ovale occlusion device in a 31-year-old woman. J Interven Cardiol 19 (2006) 166-169
80. Trepels T., Zeplin H., Sievert H., et al. Cardiac perforation following transcatheter PFO closure. Catheter Cardiovasc Interv 58 (2003) 111-113
81. Ourania Preventza O., Sampath-Kumar S., Wasnick J., et al. Late cardiac perforation following transcatheter atrial septal defect closure. Ann Thorac Surg 77 (2004) 1435-1437
82. Vojacek J., Mates M., Popelova J., et al. Perforation of the right atrium and the ascending aorta following percutaneous transcatheter atrial septal defect closure. Case report-congenital. Interact Cardiovasc Thorac Surg 4 (2005) 157-159
83. Schoen S.P., Boscheri A., Lange S.A., et al. Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patient foramen ovale. Heart 94 (2008) 844-847